Results 131 to 140 of about 19,552 (331)

Self‐Management Therapies for Temporomandibular Disorders—Evidence From Systematic Reviews

Journal of Oral Rehabilitation, EarlyView.
This umbrella review synthesized existing evidence on self‐management therapy for temporomandibular disorder. ABSTRACT Objectives Chronic pain in the orofacial region affects 10%–15% of the general population. It is most often related to temporomandibular disorders (TMD): pain in the masticatory muscles and the temporomandibular joints.
Tessa Bijelic, Ambrosina Michelotti, Rosaria Bucci, Daniela Del Sorbo, EwaCarin Ekberg, Birgitta Häggman‐Henrikson   +5 more
wiley   +1 more source

General practitioners' concepts on issuing out-of-pocket prescriptions for hypnotics and sedatives in Germany. [PDF]

Fam Pract, 2019
Schmalstieg-Bahr K, Müller CA, Hummers E.   +2 more
europepmc   +1 more source

Benzodiazepines : benefits versus risks [PDF]

, 2007
Benzodiazepines act on the central nervous system and can be prescribed for various medical conditions. They are usually classified by their duration of action.
West, Lorna Marie
core  

Preparation and characterization of vetiver oil encapsulated polymeric microcapsules for sedative and hypnotic activity

, 2019
Syed Ansar Ali, Amit Kumar Nayak, Kalyan Kumar Sen, T Prabhakar   +3 more
openalex   +2 more sources

Linkage of VA and State Prescription Drug Monitoring Program Data to Examine Concurrent Opioid and Sedative‐Hypnotic Prescriptions among Veterans [PDF]

, 2018
Kathleen F. Carlson, Tess Gilbert, Benjamin J. Morasco, Dagan Wright, Joshua Van Otterloo, Aldona Herrndorf, Lawrence J. Cook   +6 more
openalex   +1 more source

Chronic insomnia, REM sleep instability and emotional dysregulation: A pathway to anxiety and depression?

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary The world‐wide prevalence of insomnia disorder reaches up to 10% of the adult population. Women are more often afflicted than men, and insomnia disorder is a risk factor for somatic and mental illness, especially depression and anxiety disorders.
Dieter Riemann, Raphael J. Dressle, Fee Benz, Kai Spiegelhalder, Anna F. Johann, Christoph Nissen, Elisabeth Hertenstein, Chiara Baglioni, Laura Palagini, Lukas Krone, Michael L. Perlis, Katharina Domschke, Mathias Berger, Bernd Feige   +13 more
wiley   +1 more source

Pharmaceuticals, except biologicals : 2009 [PDF]

, 2011
Current industrial report.

core  

Sedative–hypnotic like effect of 5–methoxyflavone in mice and investigation on possible mechanisms by in vivo and in silico methods

, 2018
Jaikumar Shanmugasundaram, S. Viswanathan, Jagan Nadipelly, Parimala Kathirvelu, Vijaykumar Sayeli, Binoy Varghese Cheriyan   +5 more
openalex   +1 more source

Parasomnias and sleep‐related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont, Vanessa Bloch, Agnès Lillo‐Lelouet, Christine Le Beller, Pierre A. Geoffroy, Marc Veyrier   +5 more
wiley   +1 more source

Respiratory safety of lemborexant in adult and elderly subjects with moderate‐to‐severe chronic obstructive pulmonary disease

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Lemborexant 10 mg, a dual orexin‐receptor antagonist (DORA), did not elicit respiratory depressant effects, as measured by peripheral oxygen saturation (SpO2) or apnea–hypopnea index (AHI), in subjects with moderate‐to‐severe chronic obstructive pulmonary disease (COPD).
Jocelyn Y. Cheng, Daniel Lorch, Nancy Hall, Margaret Moline   +3 more
wiley   +1 more source